Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

  • 1

Latest News

  • 1
  • 2

 

NTSAD leads the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1, and Sandhoff diseases
by driving research, forging collaboration, and fostering community.

Supporting families is the center of everything we do.

Join us, learn more, and support our cause.

 

Carrier screening is not recommended for children under the age of 18, as it is not helpful in the medical care of healthy children. Once your children are 18 or older they can decide if they would like to pursue carrier screening, prior to considering reproductive options.

Login